Concepedia

Publication | Open Access

Sorafenib in Advanced Hepatocellular Carcinoma

DOIFull Paper Access

12.8K

Citations

52

References

2008

Year

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean Frédéric Blanc, André Cosme de Oliveira, Armando Santoro, Jean‐Luc Raoul, Alejandro Forner,
New England Journal of Medicine

Abstract

In patients with advanced hepatocellular carcinoma, median survival and the time to radiologic progression were nearly 3 months longer for patients treated with sorafenib than for those given placebo. (ClinicalTrials.gov number, NCT00105443.)

References

YearCitations

Page 1